Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
4.300
-0.050 (-1.15%)
Jun 3, 2026, 10:23 AM EDT - Market open
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $13.24 million as of June 3, 2026. Its market cap has decreased by -56.58% in one year.
Market Cap
13.24M
Enterprise Value
11.08M
1-Year Change
-56.58%
Ranking
Category
Stock Price
$4.30
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $13.24M, a decrease of -77.25%. That is a compound annual growth rate of -35.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 13.39M | -15.53% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akari Therapeutics, | 15.37M |
| Cocrystal Pharma | 15.30M |
| Lexaria Bioscience | 15.28M |
| OSR Holdings | 15.06M |
| Jasper Therapeutics | 14.96M |
| HCW Biologics | 14.82M |
| SeaStar Medical Holding | 14.55M |
| Moolec Science | 14.25M |